F15.982
Other stimulant use, unspecified with stimulant-induced sleep disorder
Clinical Classification Guidelines
Inclusion Terms
- Amphetamine or other stimulant-induced sleep disorder, without use disorder
- Caffeine induced sleep disorder, without use disorder
Medical Intelligence & Overview
ICD-10 Code F15.982 refers to cases where an individual experiences sleep disturbances caused by the use of stimulants such as amphetamines or caffeine, without meeting the criteria for a stimulant use disorder. This condition involves disrupted sleep patterns directly related to stimulant consumption, impacting overall health and well-being. The term 'unspecified' indicates that the exact stimulant may not be clearly identified or documented, but the sleep disorder is linked to stimulant use.
Causes & Symptoms
Clinical Causes: Use of stimulants like amphetamines, caffeine, or related substances Unintentional or intentional consumption of high doses of stimulants Regular intake of caffeine or other stimulants for alertness or performance enhancement Use of stimulants for recreational purposes Certain medications containing stimulants leading to sleep disturbances
Key Symptoms: Difficulty falling asleep (sleep onset insomnia) Frequent awakenings during the night Restless or non-restorative sleep Feelings of fatigue or tiredness during the day Increased alertness or hyperactivity Restlessness or a feeling of being 'wired' Headaches or irritability upon waking Elevated heart rate or blood pressure during sleep disturbances
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a clinical assessment where a healthcare provider reviews the individual's medical history, substance use patterns, and sleep history. Sleep disturbances caused by stimulant use are identified through patient interviews and, sometimes, sleep studies. It is important to distinguish between sleep problems directly caused by stimulants and those related to other sleep disorders or medical conditions. The absence of a substance use disorder is noted here, focusing solely on the sleep disturbance linked to stimulant intake.
Treatment Protocols: Management of stimulant-induced sleep disorder generally includes reducing or eliminating stimulant intake to improve sleep quality. Sleep hygiene education, behavioral therapies, and sometimes pharmacological interventions may be recommended. Supportive care such as stress management and relaxation techniques can also help mitigate sleep issues. In cases where caffeine or other stimulants are used intentionally, gradual reduction may be advised to prevent withdrawal symptoms and ensure better sleep patterns.
Clinical Advice & FAQs
Billing Guidance
Is F15.982 a billable ICD-10 code?
Yes, F15.982 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F15.982?
Clinical documentation must specify the nature of Other stimulant use, unspecified with stimulant-induced sleep disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
